COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

被引：0
|
作者：
Kaczor, M. P. [1 ]
Wojcik, R. [2 ]
Pawlik, D. [2 ]
Skrzekowska-Baran, I [3 ]
Tronczynski, K. [3 ]
机构：
[1] Jagiellonian Univ, Coll Med, Krakow, Poland
[2] Aestimo Sc, Krakow, Poland
[3] Janssen Cilag Polska, Warsaw, Poland
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.217
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A359 / A360
页数：2
相关论文
共 50 条
  • [31] Management of treatment-naive chronic hepatitis C genotype 1 patients: a cost-effectiveness analysis of treatment options
    Cortesi, P. A.
    Ciaccio, A.
    Rota, M.
    Lim, J. K.
    De Salvia, S.
    Okolicsanyi, S.
    Vinci, M.
    Belli, L. S.
    Mantovani, L. G.
    Strazzabosco, M.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2015, 22 (02) : 175 - 183
  • [32] Cost-Effectiveness Assessment of Telaprevir Combination Treatment Compared to Pegylated-Interferon plus Ribavirin Alone in the Management of Hepatitis C in Patients who Failed Prior Pegylated-Interferon plus Ribavirin Treatment
    Deniz, Baris
    Brogan, Anita
    Miller, Jeffrey
    Talbird, Sandra
    Thompson, James
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S410 - S410
  • [33] COST-UTILITY ANALYSIS OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALPHA AND RIBAVIRIN IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC HEPATITIS C
    Lukac, M.
    Bielik, J.
    Holoman, J.
    Tomek, D.
    Suvadova, A.
    Foltanova, T.
    Foltan, V
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A330 - A330
  • [34] COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN COLOMBIA
    Garcia Marti, S.
    Alcaraz, A.
    Valanzasca, P.
    Garay, O. U.
    McMullen, M.
    Rey Ares, L.
    Idrovo, V
    Prieto Ortiz, J.
    Tapias, M.
    Obregon, J.
    Ariza, J. G.
    Caporale, J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A693 - A693
  • [35] Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C
    Fukuda, Kazuto
    Imai, Yasuharu
    Hiramatsu, Naoki
    Irishio, Keiko
    Igura, Takumi
    Sawai, Yoshiyuki
    Kogita, Sachiyo
    Makino, Yuki
    Mizumoto, Rui
    Matsumoto, Yasushi
    Nakahara, Masanori
    Zushi, Sinichiro
    Kajiwara, Nobuyuki
    Oze, Tsugiko
    Kawata, Sumio
    Hayashi, Norio
    Takehara, Tetsuo
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (12) : 1165 - 1171
  • [36] COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA
    Garcia Marti, S.
    Alcaraz, A.
    Valanzasca, P.
    Garay, O. U.
    McMullen, M.
    Rey Ares, L.
    Obando, C. A.
    Caporale, J.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A714 - A714
  • [37] Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan
    Kumada, Hiromitsu
    Toyota, Joji
    Okanoue, Takeshi
    Chayama, Kazuaki
    Tsubouchi, Hirohito
    Hayashi, Norio
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (01) : 78 - 84
  • [38] THE COST EFFECTIVENESS OF A NOVEL HIGH PRICED COMBINATION THERAPY FOR HEPATITIS C IN TREATMENT NAIVE GENOTYPE 1 INFECTED PATIENTS
    McGinnis, J. J.
    Hay, J. W.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A238 - A239
  • [39] Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile
    Vargas, Constanza L.
    Espinoza, Manuel A.
    Giglio, Andres
    Soza, Alejandro
    [J]. PLOS ONE, 2015, 10 (11):
  • [40] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Van Baelen, B.
    Picchio, G.
    Beaumont-Mauviel, M.
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 : S27 - S27
12345